Letters

Hepatitis B vaccination policy in drug treatment services

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7018.1500 (Published 02 December 1995) Cite this as: BMJ 1995;311:1500
  1. P Mangtani, Lecturer in epidemiology,
  2. S Kovats, Research assistant,
  3. A Hall, Senior lecturer Epidemiology and Population Sciences Department
  1. Communicable Diseases Epidemiology Unit, London School of Hygiene and Tropical Medicine, London WC1E 7HT

    EDITOR,--The World Health Organisation encourages universal vaccination against hepatitis B in settings in which the prevalence is low1; current British policy recommends selective vaccination.2 We present information about the delivery of vaccine to the target group with the highest prevalence and risk of infection, injecting drug misusers.3

    Drug clinics were identified from the 1992 directory of the standing conference on drug abuse, updates, and regional drugs databases and were contacted in November 1993. Characteristics of new clients were provided by the clinics or collected from regional drugs databases. Self help groups, helplines, private nursing homes, and clinics …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe